Our API manufacturing facility “Macsen Drugs”, which is WHO-GMP certified and US-FDA registered, has obtained GMP certification from the TGA Australia.
Macsen Labs marks a key milestone in energy storage with the successful synthesis of high-performance Prussian White for advanced Sodium-Ion batteries.
We are thrilled to announce the commencement of construction of our new Active Pharmaceutical Ingredient (API) manufacturing facility.
As we conclude another remarkable year at Macsen Labs, we review a period characterized by expansion and new initiatives. This retrospective review covers our organization's key accomplishments in 2023-24.
Our API manufacturing facility “Macsen Drugs”, which is WHO-GMP certified and US-FDA registered, has obtained GMP certification from the TGA Australia.
In continuation to our mission and values, we got an opportunity to be a part of a project of re-developing a government school in Odwadiya, Udaipur, Raj.
The Indian patent office has granted a patent to Macsen Drugs. The patent concerns a novel process for synthesizing the compound "Fluorescein Sodium".
The Indian patent office granted a patent to Mr Achal Agrawal. The patent concerns a novel process for synthesizing the compound “Methylthioninium Chloride” or “Methylene Blue”.
The research and development team of Macsen Labs has invented a novel process of making fluorescein sodium in which the resultant product is almost free of water, is of high purity and has a free-flowing bright orangish colour/ appearance.